Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6459)
All Articles published online
|
Publishing Process of This Article
|
Oct 28, 2014 (publication date) through May 10, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Jones OP, Melling JD, Ghaneh P. Adjuvant therapy in pancreatic cancer. World J Gastroenterol 2014; 20(40): 14733-14746 [PMID: 25356036 DOI: 10.3748/wjg.v20.i40.14733] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i40/14733.htm |
| Number | Citing Articles |
| 1 |
Heather Peluso, Wesley B. Jones, Alexander A. Parikh, Marwan S. Abougergi. Treatment outcomes, 30‐day readmission and healthcare resource utilization after pancreatoduodenectomy for pancreatic malignancies. Journal of Hepato-Biliary-Pancreatic Sciences 2019; 26(5): 187 doi: 10.1002/jhbp.621
|
| 2 |
Lennart B. van Rijssen, Lydia G.M. van der Geest, Thomas L. Bollen, Marco J. Bruno, Ate van der Gaast, Laetitia Veerbeek, Fibo J.W. Ten Kate, Olivier R.C. Busch. National compliance to an evidence-based multidisciplinary guideline on pancreatic and periampullary carcinoma. Pancreatology 2016; 16(1): 133 doi: 10.1016/j.pan.2015.10.002
|
| 3 |
Xiaoxia Ren, Wenjing Zhao, Yongxing Du, Taiping Zhang, Lei You, Yupei Zhao. Activator protein 1 promotes gemcitabine-induced apoptosis in pancreatic cancer by upregulating its downstream target Bim. Oncology Letters 2016; 12(6): 4732 doi: 10.3892/ol.2016.5294
|
| 4 |
Abdelkader Taibi, Jeremie Jacques, Sylvaine Durand Fontanier, Aurelie Charissoux, Sylvia M. Bardet, Niki Christou, Fabien Fredon, Denis Valleix, Muriel Mathonnet. Long‐term survival after surgery of pancreatic primary squamous cell carcinoma: A case report and literature review. Clinical Case Reports 2019; 7(11): 2092 doi: 10.1002/ccr3.2429
|
| 5 |
Mushegh A. Sahakyan, Airazat M. Kazaryan, Majd Rawashdeh, David Fuks, Mark Shmavonyan, Sven-Petter Haugvik, Knut Jørgen Labori, Trond Buanes, Bård Ingvald Røsok, Dejan Ignjatovic, Mohammad Abu Hilal, Brice Gayet, Song Cheol Kim, Bjørn Edwin. Laparoscopic distal pancreatectomy for pancreatic ductal adenocarcinoma: results of a multicenter cohort study on 196 patients. Surgical Endoscopy 2016; 30(8): 3409 doi: 10.1007/s00464-015-4623-x
|
| 6 |
Quanxiao Li, Gang Yang, Mengyu Feng, Suli Zheng, Zhe Cao, Jiangdong Qiu, Lei You, Lianfang Zheng, Ya Hu, Taiping Zhang, Yupei Zhao. NF-κB in pancreatic cancer: Its key role in chemoresistance. Cancer Letters 2018; 421: 127 doi: 10.1016/j.canlet.2018.02.011
|
| 7 |
Rongkun Li, Lili Zhu, Yangxizi Peng, Xiaoxin Zhang, Chunhua Dai, Dejun Liu. TRIM50 Suppresses Pancreatic Cancer Progression and Reverses the Epithelial-Mesenchymal Transition via Facilitating the Ubiquitous Degradation of Snail1. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.695740
|
| 8 |
Adriana Harbuzariu, Gabriela Oprea-Ilies, Ruben R. Gonzalez-Perez. Advances in Pancreatic Cancer. 2018; doi: 10.5772/intechopen.76400
|
| 9 |
Malte Weinrich, Johanna Bochow, Anna-Lisa Kutsch, Guido Alsfasser, Christel Weiss, Ernst Klar, Bettina M. Rau. High compliance with guideline recommendations but low completion rates of adjuvant chemotherapy in resected pancreatic cancer: A cohort study. Annals of Medicine and Surgery 2018; 32: 32 doi: 10.1016/j.amsu.2018.06.004
|
| 10 |
Jia-Li Wang, Qinghua Quan, Ruifang Ji, Xiao-Yu Guo, Jia-Mei Zhang, Xia Li, Yong-Gang Liu. Isorhamnetin suppresses PANC-1 pancreatic cancer cell proliferation through S phase arrest. Biomedicine & Pharmacotherapy 2018; 108: 925 doi: 10.1016/j.biopha.2018.09.105
|
| 11 |
Cindy Serdjebi, Johan Gagnière, Jérôme Desramé, Francine Fein, Rosine Guimbaud, Eric François, Thierry André, Jean-François Seitz, Carole Montérymard, Dominique Arsene, Julien Volet, Abakar Abakar-Mahamat, Thierry Lecomte, Véronique Guerin-Meyer, Jean-Louis Legoux, Gaël Deplanque, Pierre Guillet, Joseph Ciccolini, Côme Lepage, Laetitia Dahan, Robert K Hills. FFCD-1004 Clinical Trial: Impact of Cytidine Deaminase Activity on Clinical Outcome in Gemcitabine-Monotherapy Treated Patients. PLOS ONE 2015; 10(8): e0135907 doi: 10.1371/journal.pone.0135907
|
| 12 |
Yunchao Wang, Jian Li, Shixiang Guo, Yongsheng Ouyang, Liangyu Yin, Songsong Liu, Zhiping Zhao, Jiali Yang, Wenjie Huang, Huan Qin, Xin Zhao, Bing Ni, Huaizhi Wang. Lin28B facilitates the progression and metastasis of pancreatic ductal adenocarcinoma. Oncotarget 2017; 8(36): 60414 doi: 10.18632/oncotarget.19578
|
| 13 |
V.O. Oria, P. Bronsert, A.R. Thomsen, M.C. Föll, C. Zamboglou, Luciana Hannibal, S. Behringer, M.L. Biniossek, C. Schreiber, A.L. Grosu, L. Bolm, D. Rades, T. Keck, M. Werner, U.F. Wellner, O. Schilling. Proteome Profiling of Primary Pancreatic Ductal Adenocarcinomas Undergoing Additive Chemoradiation Link ALDH1A1 to Early Local Recurrence and Chemoradiation Resistance. Translational Oncology 2018; 11(6): 1307 doi: 10.1016/j.tranon.2018.08.001
|
| 14 |
Javed Mahmood, Allen A. Alexander, Santanu Samanta, Shriya Kamlapurkar, Prerna Singh, Ali Saeed, France Carrier, Xuefang Cao, Hem D Shukla, Zeljko Vujaskovic. A Combination of Radiotherapy, Hyperthermia, and Immunotherapy Inhibits Pancreatic Tumor Growth and Prolongs the Survival of Mice. Cancers 2020; 12(4): 1015 doi: 10.3390/cancers12041015
|
| 15 |
Faezeh Tolue Ghasaban, Mahmoud Ghanei, Reihaneh Alsadat Mahmoudian, Negin Taghehchian, Mohammad Reza Abbaszadegan, Meysam Moghbeli. MicroRNAs as the critical regulators of epithelial mesenchymal transition in pancreatic tumor cells. Heliyon 2024; 10(9): e30599 doi: 10.1016/j.heliyon.2024.e30599
|
| 16 |
Qinggong Yuan, Yan Zhang, Junhui Li, Gang Cao, Wenbin Yang. High expression of microRNA-4295 contributes to cell proliferation and invasion of pancreatic ductal adenocarcinoma by the down-regulation of Glypican-5. Biochemical and Biophysical Research Communications 2018; 497(1): 73 doi: 10.1016/j.bbrc.2018.02.023
|
| 17 |
Yu-Qi Shi, Xiao-Chong Zhou, Peng Du, Min-Yue Yin, Lan Xu, Wen-Jie Chen, Chun-Fang Xu. Relationships are between metformin use and survival in pancreatic cancer patients concurrent with diabetes. Medicine 2020; 99(37): e21687 doi: 10.1097/MD.0000000000021687
|
| 18 |
Aldo Sainato, Sabrina Montrone, Francesco Pasqualetti, Marianna Coppola, Nunzia L.V. Cernusco, Marco Panichi, Alessandra Gonnelli, Enrico Vasile, Riccardo Morganti, Alfredo Falcone, Ugo Boggi, Fabiola Paiar. Adjuvant Chemoradiotherapy (Gemcitabine-based) in Pancreatic Adenocarcinoma: The Pisa University Experience. Tumori Journal 2017; 103(6): 577 doi: 10.5301/tj.5000664
|
| 19 |
Xiang Xia, Kundong Zhang, Gang Cen, Tao Jiang, Jun Cao, Kejian Huang, Chen Huang, Qian Zhao, Zhengjun Qiu. MicroRNA-301a-3p promotes pancreatic cancer progression via negative regulation ofSMAD4. Oncotarget 2015; 6(25): 21046 doi: 10.18632/oncotarget.4124
|
| 20 |
Chrysovalantou Mihailidou, Pavlos Papakotoulas, Athanasios G. Papavassiliou, Michalis V. Karamouzis. Superior efficacy of the antifungal agent ciclopirox olamine over gemcitabine in pancreatic cancer models. Oncotarget 2018; 9(12): 10360 doi: 10.18632/oncotarget.23164
|
| 21 |
Laura Kuhlmann, Wiebke M. Nadler, Alexander Kerner, Sabrina A. Hanke, Elisa M. Noll, Christian Eisen, Elisa Espinet, Vanessa Vogel, Andreas Trumpp, Martin R. Sprick, Christoph P. Roesli. Identification and Validation of Novel Subtype-Specific Protein Biomarkers in Pancreatic Ductal Adenocarcinoma. Pancreas 2017; 46(3): 311 doi: 10.1097/MPA.0000000000000743
|
| 22 |
Xiaoxia Ren, Yongxing Du, Lei You, Yupei Zhao. Potential functions and implications of circular RNA in gastrointestinal cancer (Review). Oncology Letters 2017; doi: 10.3892/ol.2017.7118
|
| 23 |
A Acharya, S R Markar, M H Sodergren, G Malietzis, A Darzi, T Athanasiou, A Z Khan. Meta-analysis of adjuvant therapy following curative surgery for periampullary adenocarcinoma. British Journal of Surgery 2017; 104(7): 814 doi: 10.1002/bjs.10563
|
| 24 |
Zhuanglin Li, Mingxue Wang, Xuejing Yao, Wenting Luo, Yaocheng Qu, Deling Yu, Xue Li, Jianmin Fang, Changjiang Huang. Development of a Novel EGFR-Targeting Antibody-Drug Conjugate for Pancreatic Cancer Therapy. Targeted Oncology 2019; 14(1): 93 doi: 10.1007/s11523-018-0616-8
|
| 25 |
Dietrich A. Ruess, Frank Makowiec, Sophia Chikhladze, Olivia Sick, Hartwig Riediger, Ulrich T. Hopt, Uwe A. Wittel. The prognostic influence of intrapancreatic tumor location on survival after resection of pancreatic ductal adenocarcinoma. BMC Surgery 2015; 15(1) doi: 10.1186/s12893-015-0110-5
|
| 26 |
Weiliang Jiang, Qiongying Yuan, Yuanye Jiang, Li huang, Congying Chen, Guoyong Hu, Rong Wan, Xingpeng Wang, Lijuan Yang. Identification of Sox6 as a regulator of pancreatic cancer development. Journal of Cellular and Molecular Medicine 2018; 22(3): 1864 doi: 10.1111/jcmm.13470
|